A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)

Yutaka Ogata, Mototsugu Shimokawa, Takaho Tanaka, Yasunori Emi, Eiji Oki, Hiroshi Saeki, Noriaki Sadanaga, Tetsuya Kusumoto, Tetsuo Touyama, Masami Kimura, Hideo Baba, Yoshito Akagi, Kazuo Shirouzu, Yoshihiko Maehara

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)'. Together they form a unique fingerprint.

Medicine & Life Sciences